BioSpace News Archive

Deals

Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer

Rezolute, Inc. today announced the addition of Daron Evans, MS, MBA, to its leadership team as Chief Financial Officer as well as the grant of share options as a material inducement for his appointment (the “Inducement Grant”).

January 24, 2024
·
5 min read
Biotech Beach

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the second interim report from an ongoing clinical trial designed to support establishing OGM as part of standard of care (SOC) in diagnosis of genetic disease for prenatal subjects.

January 24, 2024
·
9 min read
Business

10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Thursday, February 15, 2024.

January 24, 2024
·
1 min read
Pharm Country

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Inventiva announced the half-year report of its liquidity contract with Kepler Cheuvreux.

January 24, 2024
·
13 min read
Business

IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024

IQVIA Holdings Inc. will announce its fourth-quarter and full-year 2023 financial results before the market opens on Wednesday, February 14, 2024.

January 24, 2024
·
2 min read
Pharm Country

Astrin Biosciences and Leading New York Cancer Center Announce New Cancer Research Collaboration

In a significant advancement for cancer research and treatment, Astrin Biosciences, a leader in AI-empowered 3D holographic technology for cancer cell detection, has announced a comprehensive research collaboration with Memorial Sloan Kettering Cancer Center.

January 24, 2024
·
1 min read
Pharm Country

UroGen Initiates Submission of a Rolling NDA to the FDA for UGN-102

UroGen Pharma Ltd. today announced the submission of the Chemistry, Manufacturing, and Controls (CMC) section of the New Drug Application (NDA) for UGN-102 (mitomycin) for intravesical solution to the U.S. Food and Drug Administration (FDA).

January 24, 2024
·
5 min read
Business

ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer

ZWI Therapeutics, Inc. announces a Series A financing, the appointment of pharmaceutical industry veterans Drs. Larry Miller and Ron Cohen as Independent Directors to the company’s Board of Directors.

January 24, 2024
·
8 min read
Biotech Bay

Twist Bioscience Expands Express Genes Rapid Synthesis Service

Twist Bioscience Corporation today announced the expansion of Twist Express Genes, a new leading gene synthesis service with an order to shipping turnaround starting at five business days 1, to include larger DNA preparations up to 1 milligram.

January 24, 2024
·
6 min read
Genetown

Optikos Announces New ColliMeter™ Measurement Tool

Optikos is excited to announce the release of their ColliMeter™ measurement system for the precise setup and qualification of collimators.

January 24, 2024
·
2 min read